During the past decade, Hopital de la Cite-de-la-Sante conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 13 clinical trials were completed, i.e. on average, 81.3% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 9 clinical trials were completed. i.e. 128.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hopital de la Cite-de-la-Sante" #1 sponsor was "Canadian Cancer Trials Group" with 5 trials, followed by "National Cancer Institute (NCI)" with 3 trials sponsored, "Hamilton Health Sciences Corporation" with 2 trials sponsored, "Université de Montréal" with 2 trials sponsored and "AVEO Pharmaceuticals, Inc." with 2 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital de la Cite-de-la-Sante" #1 collaborator was "AstraZeneca" with 3 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator, "National Cancer Institute (NCI)" with 3 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 2 trials as a collaborator and "Alliance for Clinical Trials in Oncology" with 1 trials as a collaborator. Other collaborators include 24 different institutions and companies that were collaborators in the rest 34 trials.

According to Clinical.Site data, the most researched conditions in "Hopital de la Cite-de-la-Sante" are "Colorectal Cancer" (4 trials), "Breast Cancer" (3 trials), "Myocardial Infarction" (2 trials), "ARDS" (1 trials) and "Acute Coronary Syndrome" (1 trials). Many other conditions were trialed in "Hopital de la Cite-de-la-Sante" in a lesser frequency.

Most popular intervention types in "Hopital de la Cite-de-la-Sante" are "Drug" (19 trials), "Other" (13 trials), "Biological" (4 trials), "Radiation" (4 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Durvalumab" (3 trials), "Pembrolizumab" (3 trials), "Quality-of-Life Assessment" (3 trials) and "Tremelimumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Hopital de la Cite-de-la-Sante" are 27 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hopital de la Cite-de-la-Sante". 1 are not yet recruiting, 4 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Hopital de la Cite-de-la-Sante, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Hopital de la Cite-de-la-Sante, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".